AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2010
Feb 3, 2010
32870_dirs_2010-02-03_eba87be9-6c51-4cbb-8d62-30c1f2c2abc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2009-09-10
Reporting Person: El-Hibri Fuad (Director, CEO and Chairman, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-09-10 | Employee Stock Option (right to buy) | $3.5 | M | 47600 | Disposed | 2010-05-25 | Common Stock (47600) | Direct |
| 2009-09-11 | Employee Stock Option (right to buy) | $3.5 | M | 27900 | Disposed | 2010-05-25 | Common Stock (27900) | Direct |
| 2009-09-14 | Employee Stock Option (right to buy) | $3.5 | M | 37700 | Disposed | 2010-05-25 | Common Stock (37700) | Direct |
| 2009-09-15 | Employee Stock Option (right to buy) | $3.5 | M | 16270 | Disposed | 2010-05-25 | Common Stock (16270) | Direct |
Footnotes
F1: These exercises were originally reported on a Form 4 filed on September 14, 2009 by the reporting person.
F2: The Form 4s filed by the reporting person on September 14, 2009 and September 16, 2009 inadvertently listed an incorrect number of derivative securities beneficially owned by the reporting person in column 9. Column 9 inadvertently included 86,312 employee stock options that were exercised on November 17, 2006. Column 9 of Table II of the Form 4s have been amended accordingly.
F3: These exercises were originally reported on a Form 4 filed on September 16, 2009 by the reporting person.